>
Switch to:

BridgeBio Pharma DeferredTaxAndRevenue

: $0.00 Mil (As of Sep. 2020)
View and export this data going back to 2019. Start your Free Trial

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

BridgeBio Pharma's current deferred tax and revenue for the quarter that ended in Sep. 2020 was $0.00 Mil.

BridgeBio Pharma DeferredTaxAndRevenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
DeferredTaxAndRevenue 0.00 0.00 0.00

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
DeferredTaxAndRevenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BridgeBio Pharma DeferredTaxAndRevenue Related Terms


BridgeBio Pharma DeferredTaxAndRevenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)